1/81
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Blepharospasm
Squinting
Iridocyclitis
Inflammation of the iris and ciliary body, also called anterior uveitis
Keratomalacia
‘Melting’ or collagenolysis of the cornea
Photophobia
Greater than normal sensitivity to light
Epiphora
Excessive lacrimation or tearing
Endophthalmitis
Inflammation of the internal structures within the globe, often caused by infection; can be a complication of intraocular surgery
Hyphema
RBCs within the anterior chamber
Hypopyon
WBCs within the anterior chamber
Synechia
Adhesion between the cornea and iris (anterior) or the iris and lens (posterior)
Seidel Test
Application of concentration fluorescein, which appears orange, to the corneal surface to detect a perforation. A perforation, or leak, appears as dilute fluorescein (fluorescent green with a cobalt blue light) at the site of the leak, surrounded by the concentration fluorescein
Uveitis
Inflammation of the uvea, which is the middle layer of the eye between the sclera and retina, including the iris, the choroid of the eye, and the ciliary body
Indications for Auriculopalpebral Nerve Block
Provides akinesia of the orbicularis oculi muscle
Used to prevent eyelid closure
Indications for Supraorbital (Frontal) Nerve Block
Frontal nerve innervates the medial and central upper lid
Can be blocked at the supraorbital foramen, a depression medial to the narrowest aspect of the supraorbital process of the frontal bone
Performed prior to placement of an upper lid SPL
Auriculopalpebral Nerve Block Technique
Palpated just latera to the dorsal most border of the zygomatic arch and on the zygomatic arch caudal to the bony process of the frontal bone
Can also be blocked just anterior to the base of the ear where the nerve cannot be palpated
Supraorbital (Frontal) Nerve Block Technique
Insert the needle into or just over the supraorbital foramen
What innervates the lateral upper lid?
Lacrimal nerve
Where can the lacrimal nerve be blocked?
Along the lateral aspect of the orbital rim
What innervates the medial aspect of the lower lid and the medial canthus?
Infratrochlear nerve
Where can the infratrochlear nerve be blocked?
At the palpable trochlear notch, on the medial aspect of the orbital rim
What innervates the lower lid?
Zygomatic nerve
Where can the zygomatic nerve be blocked?
Along the ventrolateral orbital rim
Indications for a Conjunctival Graft
Used for deep corneal ulcers and other corneal wounds when the lesion extends to or close to Descemet's membrane
Grafts provide blood supply, fibroblasts, anticollagenases, and support for weakened corneal stroma
Complications of a Conjunctival Graft
Dehiscence and infection
If the conjunctiva used for the graft is too thick, extensive scarring can cause loss of vision
Indications for Tarsorrhaphy
Surgical closure of the eyelid
Can be partial or complete and temporary or permanent
Temporary tarsorrhaphy is most commonly performed to facilitate corneal wound healing, to protect the cornea, during recovery from anesthesia following corneal surgery, and to support the surgical site during healing following corneal surgery
A partial temporary tarsorrhaphy may also be performed to prevent corneal dessication in cases of facial nerve paralysis
Complications of Tarsorrhaphy
An improperly placed tarsorrhaphy can cause corneal injury with ulceration as a consequence of the suture material rubbing against the cornea
Indications for Enucleation
Severe ocular trauma, infection, and endophthalmitis
Surgical Approach for Enucleation
Transpalpebral - indicated for infectious or neoplastic disease
Transconjunctivals - may be preferred for glacomatous or uveitic globes
Conjunctiva, globe, and nictitating membrane are completely removed
Complications of Enucleation
Most common complication is swelling, which may be associated with hemorrhage
Infection can occur and is managed with drainage
Complications associated with prosthesis placement include prosthesis shifting, surgical wound dehiscence, and prosthesis extrusion
Management/Treatment of Eyelid Laceration
The wound should be minimally debrided without excising tissue
If the eyelid margin and palpebral fissure cannot be restored with available tissue, blepharoplastic procedures such as sliding skin grafts are warranted
Wounds should be closed in two layers to prevent dehiscence of the deep conjunctival layer and subsequent cornea ulceration from mechanical trauma
A figure of eight suture pattern at the eyelid margin is critical to achieve perfect apposition and prevent cicatricial entropion, secondary corneal damage, and potential globe loss
Suture placement should begin at the eyelid margin or the base of the wound and work toward the apex of the laceration to ensure perfect eyelid apposition
The use of topical antimicrobials can be associated with excessive granulation tissue and wound dehiscence if the upper eyelid is manipulated and in particular forced open when medication is applied so use of topical antimicrobials is discouraged
Prognosis for retention of lid function is typically good but lid margin irregularities and mechanical or exposure keratitis may result
Etiology/Pathogenesis of Entropion
Most common in the lower lid in recumbent neonatal foals with systemic disease that typically have impaired corneal sensitivity and enophthalmos secondary to dehydration, insufficient body fat, or abnormal globe position
Can occur as a primary anatomic disease but this is uncommon
Management/Treatment of Entropion
Temporary surgical imbrication of the lower lid in foals with entropion secondary to systemic disease is typically all that is warranted
Entropion in these foals is generally self-correcting with the resolution of systemic disease
Imbrication is best performed using interrupted sutures in a vertical mattress pattern entirely on the lower lid
Cicatricial entropion should be corrected with blepharoplastic procedures as dictated by the lid conformation
Improper repair can be associated with impaired lid function, persistent corneal ulceration, and loss of the globe
Orbital Fracture Management/Treatment
Minor orbital rim fractures rarely require surgical treatment
Open fractures should be debrided and lavaged
Small bone fragments should be removed to avoid sequestrum formation
Large fractures causing extensive facial deformity and/or impinging or entrapping the globe should be surgically repaired
Should be performed within days of injury because fibrous union occurs within 1 week
Involves elevating the fragments into the normal position and stabilizing the fracture with monofilament stainless steel, cerclage wire, small pins, or orthopedic bone plates
Ophthalmic complications include corneal ulcers, iridocyclitis, entrapment of the globe by bone fragments, and blindness
Corneal Ulceration
Loss of corneal epithelium resulting in exposed corneal stroma
Corneal Ulceration Etiology/Pathogenesis
Conjunctiva and cornea are constantly bathed in bacteria and fungus which quickly adhere to exposed stroma
Consider secondary infection in ulcers that do not improve or worsen within a few days
Microbial and ubiquitous tear film proteinases may contribute to the progression of the corneal injury, resulting in keratomalacia characterized by a 'melting' cornea
Corneal Ulceration Clinical Features
Nonspecific signs: epiphora, ocular discharge, conjunctival hyperemia, blepharospasm, photophobia, and corneal edema
Ulcer depth can range from superficial abrasions to extremely deep erosions
A descemetocele is the result of complete stroma loss and exposure of the thin Descemet's membrane
Keratomalacia and corneal neovascularization may also be apparent
Corneal Ulcer Diagnosis
Positive uptake of fluorescein stain is diagnostic for a corneal ulcer and will appear green in the exposed stroma with a cobalt blue light
Rose Bengal dye positively stains degenerate or dead epithelial cells and can be used to identify early disease
Descemet's membrane does not stain with fluorescein so a descemetocele will have a fluorescein-stained outer ring of exposed stroma with a non-staining center
A corneal scraping should be obtained with a cotton swab or the blunt end of a scalpel blade and submitted for
Bacterial culture
Fungal culture
Cytology
Healing of Uncomplicated Superficial Ulcers
Occurs by migration and mitosis of epithelial cells and is completed in 5-7 days
Medical Therapy for Corneal Ulcers
Antimicrobial drugs (broad spectrum) such as triple antibiotics
Antifungal chosen based on geography
Atropine is used to treat uveitis by reducing ciliary spasm and preventing iris to lens adhesions, which can occur with prolonged miosis
Autologous serum is a broad-spectrum anticollagenase that should be used to inhibit proteinases released by infectious organisms and WBCs and in the tear film
Systemic NSAIDs
Topical antimicrobials should be continued until the cornea has completely epithelialized
Surgical Therapy for Corneal Ulcers
Corneal grafts are indicated in cases of severe and deep ulcers and those not responding to medical therapy
Biomaterial indicated in each case is determined by the reason for the graft
Optical, to restore or improve vision
Therapeutic, to control medically refractory corneal disease
Tectonic, to preserve or restore the structural integrity of the globe when tissue is missing
Cosmetic, to improve the appearance of the globe without necessarily improving vision
Conjunctival grafts are indicated to bring blood supply to the ulcerated cornea for therapeutic and tectonic reasons, but can be associated with significant scarring
Pedicle conjunctival grafts are the most commonly used
Hood or bipedicle (bridge) conjunctival grafts may be used to bring a blood supply to larger ulcers
When the stromal defect is deep or an iris prolapse has developed, a corneal graft (fresh or frozen) may be used underneath the conjunctival graft to replace missing tissue
In cases of extreme keratomalacia or for ulcers with a large surface area, an amniotic membrane transplant may be warranted
Amniotic membrane can provide significant structural support
Amnion has antiangiogenic, anti-inflammatory, and antimicrobial properties that contribute to healing
Amnion typically sloughs off as the underlying cornea heals
Treatment should be continued until the cornea is completely epithelialized and the graft material (conjunctiva, cornea, or amnion) has become incorporated into or sloughed from the recipient cornea
Usually at least 2 weeks postoperatively
Anti-inflammatory therapy is sometimes required longer term (weeks to months) to control keratitis and uveitis associated with grafting procedures
Prognosis for Corneal Ulcers
Prognosis for retention of vision depends on the resulting corneal scar as well as the presence of a pupillary opening
Prognosis for retention of the globe depends on maintenance of structure integrity of the globe
Corneal Burn
A corneal burn occurs with corneal exposure to a chemical or naturally occurring substance, including ultraviolet light, which causes a corneal ulcer
Corneal Burn Etiology/Pathogenesis
Can occur following corneal exposure to any substance that is irritating, an acid or base (chemical burn) or to ultraviolet light (i.e. flash burn)
Severity depends on the cause, the cornea, and the initial treatment
Alkali burns caused by a substance with a pH >7 are the most dangerous because these substances react with fat in the cornea to form soap and so the damage can rapidly progress to Descemet's membrane and result in perforation
Acids with a pH <7, precipitate with stromal proteins so these burns are typically self-limiting
Irritants with a neutral pH tend to cause more discomfort to the eye than actual damage
Can also occur as a result of thermal injury (e.g. barn fires)
Corneal Burns Clinical Features
Damage typically limited to the cornea and conjunctiva but in severe cases the globe may rupture
Signs of a corneal burn include blepharospasm, blepharitis, conjunctival hyperemia and chemosis, and epiphora
Corneal Burns Diagnosis
Use fluorescein stain to determine if an ulcer is present and if so evaluate the depth
Corneal Burns Management/Treatment
Immediate copious lavage with sterile saline or clean water if saline isn't available, is critical to stop chemical degradation of the cornea
Medical treatment includes a topical broad-spectrum antimicrobial, a mydriatic, and anti-collagenase therapy
Systemic NSAIDs
Do sharp force or blunt force corneal injuries have a better prognosis?
Sharp force corneal injuries have a better prognosis than blunt force injuries and injuries involving the sclera
Corneal Laceration Clinical Features
Affected eye is frequently cloudy, red and painful
Blepharospasm, lacrimation, and corneal edema at the wound margins
With a full-thickness laceration or corneal perforation, iris prolapse, anterior chamber collapse, and severe iridocyclitis (i.e. anterior uveitis) will be present
Corneal Laceration Management/Treatment
Superficial corneal lacerations can be managed with medical treatment
Surgical repair is indicated for deep lacerations or corneal perforation and should be performed as soon as possible
Primary closure of the cornea is recommended and covering the laceration with a conjunctival graft may be warranted
If the iris is prolapsed, the necrotic tissue should be sharply removed and the remaining iris pushed back into the eye
The anterior chamber may be re-established with sodium hyluronate, irrigation solution, or an air bubble
In severely infected or severely traumatized eyes, enucleation should be considered
Prognosis depends on the chronicity, size, and location of the laceration
Full-thickness wounds >15 mm, corneal ulcers older than 2 weeks, and lacerations that extend along or past the limbus carry a poorer prognosis
Corneal Stromal Abscess
A corneal stromal abscess is a focal abscess in the stroma covered by epithelial cells
Corneal Stromal Abscess Etiology/Pathogenesis
A corneal stromal abscess is formed by the migration of epithelial cells over a corneal injury, which seals infected material in the corneal stroma
The lack of blood vessels and lymphatics within the cornea slows the recognition and removal of foreign material by the immune system
The abscess may be bacterial, fungal, or sterile; however, epithelial cells are more likely to cover fungal hyphae and 56% of stromal abscesses are fungal in origin
Treatment of an epithelialized ulcer with topical corticosteroids to reduce the resultant scar is a risk factor for the development of a stromal abscess because even though the epithelium may have completely migrated over an ulcer, infectious organisms may still be present within the stroma and infection can be exacerbated by corticosteroid treatment
Corneal Stromal Abscess Clinical Features
A focal white or yellow opacity within the corneal stroma is highly suggestive of stroma abscessation
Stromal abscesses are typically disproportionately painful relative to the apparent severity of the lesion
Abscess is commonly singular and centrally or paracentrally located, but multiple and peripheral lesions have also been noted
Clinical signs include corneal edema, blepharospasm, epiphora, photophobia, aqueous flare, and anterior uveitis
Variable corneal vascularization is noted in chronic lesions
Corneal Stromal Abscess Diagnosis
Fluorescein dye retention will typically be negative
Sampling of a deep abscess tissue is only achieved with surgery
Medical Management of Corneal Stromal Abscess
Broad-spectrum antimicrobials
Antifungals
Atropine
There has been concern regarding the ability of topical antimicrobial drugs to penetrate the corneal epithelium, but the inflamed cornea may allow adequate penetration even through an intact epithelium so debridement may not be necessary
Most abscesses are centrally located and healing is not complete until vascularization, the duration of treatment can be long
Systemic antimicrobial or antifungal drugs may be useful if there is good corneal blood supply
Systemic NSAIDs
Surgical Therapy of a Corneal Stromal Abscess
Corneal debridement with or without a conjunctival graft can be successful in cases of superficial lesions
With deep lesions, abscess removal and replacement with donor cornea using a penetrating keratoplasty, posterior lamellar keratoplasty, or deep endothelial lamellar keratoplasty is recommended
Immune Mediated Keratitis
Defined by corneal opacity or infiltrate that is typically non-infectious, not associated with severe pain or uveitis, and responds to varying degrees, based on the depth of the infiltrate, to anti-inflammatory therapy
Immune Mediated Keratitis Etiology/Pathogenesis
Inciting cause not known, but may be a self-antigen or a foreign protein that stimulates an immune response
Histology reveals lymphoplasmacytic inflammation, stromal fibrosis, and vascularization, with neutrophils also evident in more acute (i.e. <12 months) cases and mineralization identified in more chronic (i.e. >24 months) cases
Immune-Mediated Keratitis Clinical Features
Manifests as a white or yellowish-white corneal opacity at varying depths in the stroma which may or may not be accompanied by corneal edema and vascularization
Blepharospasm, epiphora, aqueous flare, and miosis, are typically not seen
Immune Mediated Keratitis Diagnosis
Based on clinical signs including measurement of IOP as well as by response to anti-inflammatory therapy
Immune Mediated Keratitis Management/Treatment
Topical anti-inflammatories including corticosteroids and immunosuppressive drugs such as cyclosporine
Superficial and mid-stromal lesions are more likely to respond to topical therapy than deep endothelial lesions
Surgical intervention via keratectomy to remove the infiltrate may be curative
Equine Recurrent Uveitis
Characterized by multiple episodes of intraocular inflammation
Equine Recurrent Uveitis Etiology/Pathogenesis
Inciting cause often unknown
Preponderance of T lymphocytes suggests that ERU is an immune-mediated delayed-type hypersensitivity reaction
Leptospira are commonly incriminated, but other bacteria and EHV have been implicated as possible causes
Appaloosas are 8.3 times more likely than other breeds to develop ERU
Clinical Features of Equine Recurrent Uveitis
Blepharospasm, miosis, and excessive lacrimation are common
In acute episodes, corneal edema, conjunctival hyperemia, and ciliary injection may be noted
Aqueous flare (cloudy anterior chamber) and hypopyon or hyphema may also be present
In chronic cases, corneal scarring, corpra nigra atrophy, posterior synechia, and cataract formation can be noted
Diagnosis of Equine Recurrent Uveitis
Based on clinical signs and recurrence of uveitis
Fluorescein dye retention is typically negative but secondary corneal disease, such as calcific band keratopathy, can complicate ERU and IOP is typically low, but secondary glaucoma can develop if cells and protein accumulate in the iridocorneal angle
Leptospiral serology is useful for assessment of previous exposure to this risk factor
Management/Treatment of Equine Recurrent Uveitis
Goals of therapy are to reduce pain, preserve vision, and minimize recurrence
Topical atropine and corticosteroids and systemic NSAIDs are typically indicated
Cyclosporine implants decrease the frequency and severity of uveitis flare-ups
Tend to have the best results when placed in a quiet eye
May need repeat implants after depletion of the drug, ~4 years
Hyphema Etiology/Pathogenesis
Causes include causes of third compartment bleeds elsewhere in the body, most notably trauma, inflammation, coagulopathy, and neoplasia
Traumatic hyphema and hyphema secondary to severe uveitis are most common in the horse
Hyphema Clinical Features
Red appearance behind the cornea which may be partial or complete
Often accompanied by corneal edema associated with inflammation of and damage to the corneal endothelium
Secondary glaucoma is a concern as red cells can occlude the iridocorneal angle
Measurement of IOP is critical to direct medical therapy
Hyphema Diagnosis
Evaluation of the indirect PLR can help establish the potential for return of vision once the hyphema resolves, but absence of an indirect pupillary light reflex can be the result of failure of light to reach the retina due to obstruction by dense anterior chamber blood
If corneal edema or hyphema precludes evaluation of structures posterior to the cornea, ocular ultrasound should be performed
Retinal detachment, lens luxation, or intraocular neoplasia may be underlying etiologies for hyphema and can potentially be identified ultrasonographically
Hyphema Management/Treatment
Stopping the bleeding for sources that are amenable to therapy, reducing inflammation associated with frank blood in the anterior chamber, and facilitating resorption of blood
Topical and systemic anti-inflammatory drugs are the primary medical therapies
Caution in use of topical corticosteroids as corneal ulceration is potentially associated with hyphema
Caution with the use of mydriatics because IOP can increase rapidly as RBCs occlude the iridocorneal drainage angle
Anti-inflammatory and mydriatic therapy may need to be continued long term, even after hyphema has apparently resolved, to reduce synechia formation and decrease the likelihood of cataract formation
Retinal Detachment
Separation of the neurosensory retina from the pigmented epithelium
Retinal Detachment Etiology/Pathogenesis
Occurs when the interface between the retinal pigmented epithelium and the neurosensory retina is disrupted
May be accomplished by fluid accumulation, hemorrhage, or during blunt force trauma
Also a complication of ERU
Retinal Detachment Clinical Features
Evaluation of the fundus will reveal an elevated hazy area in the retina in partial tears or a gray, floating veil of tissue extending into the vitreous in complete tears
Acute blindness or slowly progressing loss of vision may be appreciated
Retinal Detachment Diagnosis
If the cornea is opaque, the vitreous is cloudy or bloody, or a cataract is present, ultrasonographic examination may be necessary to obtain a diagnosis
Seagull sign may be noted on ultrasonographic examination in a complete detachment
Retinal Detachment Management/Treatment
Treatment of the underlying source of inflammation is indicated
Prognosis for retinal reattachment and return of vision in the detached area is poor
Glaucoma
Optic neuropathy associated with abnormal aqueous outflow resulting in elevated IOP
Glaucoma Etiology/Pathogenesis
Results when outflow of aqueous humor is impaired
Can occur as primary disease associated with abnormal conformation of the iridocorneal angle, or as secondary disease
Primary disease not well described in horses
Secondary glaucoma has numerous mechanisms including contraction of preiridial fibrovascular membranes (which form as a result of uveitis), occlusion of the iridocorneal angle by cellular debris or protein (as with uveitis or hyphema), posterior synechia (adhesion of the iris to the cornea) causing pupillary block, or mechanical obstruction as with lens luxation, intraocular tumor (e.g. melanoma), or infectious endophthalmitis
Glaucoma Clinical Features
Associated with increased IOP, but pressure in a uveitic eye with secondary glaucoma may be normal
Normal range of IOP in horses is generally 18-28 mmHg
Typically manifests clinically as corneal edema with a dilated pupil, but may be accompanied by signs of uveitis such as corneal vascularization, aqueous flare, and miosis
Bupthalmos develops with very high IOPs in horses
Once it develops it typically doesn't resolve
On evaluation of the iridocorneal angle, the pectinate ligament appears abnormal
Glaucoma Diagnosis
Measurement of IOP is necessary but not sufficient to diagnose glaucoma
IOP must be interpreted in the context of the remainder of the ocular examination including globe size, globe position, and pupil size
Examine the iridocorneal angle
Additional diagnostics that may provide more information about visual prognosis include ocular ultrasound and electroretinography
Glaucoma Management/Treatment
Management is directed at decreasing IOP and controlling any associated primary disease process that underlies secondary glaucoma
Medical therapy is generally directed at one of two mechanisms
Decrease in the rate of aqueous production
Increase in the rate of aqueous outflow
Drugs that decrease aqueous production in horses: beta blockers (timolol) and carbonic anhydrase inhibitors (dorzolamide)
Prostaglandin analogs (latanoprost) don't work in horses
Surgical therapy includes procedures targeted towards decreasing aqueous production and those intended to increase aqueous outflow
Aqueous production can be decreased by damaging the ciliary body, either with cryotherapy or laser therapy
Cryotherapy is associated with severe postoperative inflammation and is best reserved for use in permanently blind eyes
Transcleral cyclophotocoagulation with a diode laser is used but topical therapy must also be used after
Increased aqueous drainage from the eye can be accomplished via a gonioimplant, which bypasses the obstructed iridocorneal angle and directs aqueous humor to the subconjunctival space where it is absorbed into the bloodstream
Experimental in horses
Acute Bilndness Etiology/Pathogenesis
Often traumatic
Many causes
An obstruction in the normally clear ocular media
Bullous separation of, or a tear in, the neurosensory retina from the outer retinal pigmented epithelium
Acute glaucoma
Optic nerve ischemia related to acute blood loss
Optic neuritis
Surgical ligation of the internal or external carotid artery can cause ischemic optic neuropathy and acute, permanent blindness
Optic neuritis can be caused by parasites, recurrent uveitis, encephalomyelitis, and neoplasia
Acute Blindness Clinical Features
In cases where blindness is retinal in origin, or involves structures involved in the PLR including the optic nerve, mydriasis is the hallmark
Horses with central or cortical blindness but normal retinas and optic nerves will typically have intact PLRS, but still be blind
Acute Blindness Diagnosis
Electroretinography can be used to evaluate retinal function and differentiate between retinal and non-retinal blindness
Ocular ultrasound examination for retinal detachment
Acute Blindness Management/Treatment
Directed at the underlying disease process
Optic neuritis - treatment with systemic corticosteroids
Prognosis for return of vision depends on the nature of the underlying disease and response to treatment